Vortx Rx - Histotripsy BPH Device

DEVICE2 trials

Sponsors

HistoSonics, Inc.

Conditions

Benign Prostatic Hyperplasia (BPH)

Unknown Phase

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)

WithdrawnNCT01775488

HistoSonics, Inc.Benign Prostatic Hyperplasia (BPH)

Start: 2013-06-30Updated: 2015-08-19

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)

TerminatedNCT01896973

HistoSonics, Inc.Benign Prostatic Hyperplasia (BPH)

Start: 2013-07-31End: 2016-12-31Updated: 2023-11-07